The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequency of actionable cancer predisposing germline mutations in patients with lung cancers.
 
Semanti Mukherjee
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Research Funding - Regeneron
 
Marjorie Glass Zauderer
Consulting or Advisory Role - AstraZeneca/MedImmune; Sellas Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Epizyme (Inst); MedImmune (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst); Verastem (Inst)
 
Vignesh Ravichandran
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Nisha Pradhan
No Relationships to Disclose
 
Ahmet Zehir
No Relationships to Disclose
 
Steven M. Lipkin
No Relationships to Disclose
 
Preethi Srinivasan
No Relationships to Disclose
 
Chaitanya Bandlamudi
No Relationships to Disclose
 
Barry S. Taylor
No Relationships to Disclose
 
David Randolph Jones
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose
 
Michael F. Berger
Research Funding - Illumina
 
David B. Solit
Honoraria - Loxo; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Optos (I); Regeneron (I)
 
Joseph Vijai
No Relationships to Disclose
 
Kenneth Offit
No Relationships to Disclose